Effect of Heparin-Derived Oligosaccharide on bFGFR1 and bFGFR2 in Vascular Smooth Muscle Cells

Abstract

Our purpose is to investigate the inhibitory effect and mechanisms of heparin-derived oligosaccharide (HDO) on proliferation of vascular smooth muscle cells (VSMCs) induced by basic fibroblast growth factor (bFGF). Proliferation of VSMCs was measured by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide; cell cycle distribution was analyzed by flow cytometry; bFGF receptor 1 and receptor 2 (bFGFR1 and bFGFR2) messenger RNA (mRNA) expression levels were determined by reverse transcription–polymerase chain reaction; and its protein expression levels were detected by Western blotting and immunocytochemical methods. Results showed that HDO inhibited VSMC proliferation in a dose-dependent manner; HDO inhibited cells in G1 phase entering the S phase; HDO inhibited bFGFR1 and bFGFR2 mRNA expression levels. In addition, bFGFR1 and bFGFR2 protein expression levels were significantly inhibited by HDO dose dependently. These results imply that HDO can inhibit VSMC proliferation. The proliferation of bFGF-induced VSMCs by HDO is associated with the inhibition of bFGFR1 and bFGFR2 expression levels. This altered molecular signature may explain one mechanism of HDO-mediated inhibition of VSMC proliferation.

Keywords

heparin-derived oligosaccharide (HDO)vascular smooth muscle cell (VSMC)basic fibroblast growth factor (bFGF)proliferation

Get full access to this article

View all access options for this article.

References

Rivard

Andres

. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol. 2000;15(2):557–571.

Nelson

Cecconi

Roberts

Aruffo

Linhardt

Bevilacqua

. Heparin oligosaccharides bind L- and P-selection and inhibit acute inflammation. Blood. 1993;82(11):3253–3258.

Rabini

Staffolani

Fumelli

Mutus

Curatola

Mazzanti

. Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients. Diabetologia. 1998;41(1):101–104.

Coumoul

Deng

. Role of FGF receptors in mammalian development and congential diseases. Birth Defects Res Part C Embryo Today. 2003;69(4):286–304.

Eswarakumar

Lax

Schlessinger

. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16(2):139–149.

Aigner

Renneberg

Bojunga

Apel

Nelson

Czubayko

. Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo. Oncogene. 2002;21(37):5733–5742.

Deng

Wynshaw-boris

Shenm

Daugherty

Ornitz

Leder

. FGFR-1 is required for early post implantation growth and axial organization. Genes Dev. 1994;8(24):3045–3057.

Arman

Haffner-Krausz

Chen

Heath

Lonai

. Targeted disruption of fibroblast growth factor(FGF) receptor2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci U S A. 1998;95(9):5082–5087.

Conti

Lazzerini

. Glycosaminoglycan polysulfate(Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(6):977–981.

10.

Ahmed

Ungo

Zhou

Campo

. Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides. J Appl Physiol. 2000;88(5):1721–1729.

11.

Niu

. Preparation of heparin derived oligosaccharides and effection of them on vascular smooth muscle cells proliferation. Pharm Biotec. 2009;16(5):46–49.

12.

Linares

Perales

Palomino-Morales

Castillo

Alejandre

. Nutritional control. Gene regulation, and transformation of vascular smooth muscle cells in atherosclerosis. Cardiovasc Hematol Disord Drug Targets. 2006;6(3):151–168.

13.

Owens

Kumar

Wamhoff

. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84(3):767–801.

14.

Katsuda

Boyd

Fligner

Ross

Gown

. Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol. 1992;140(4):907–914.

15.

Muenke

Schell

. Fibroblast growth factor receptor mutations in human skeletal disorders. Trends Genet. 1995;11(8):308–313.

16.

Kastan

Bartek

. Cell cycle checkpoints and cancer. Nature. 2004;432(7015):316–323.

17.

Guimond

Turnbull

. Fibroblast growth factor receptor signaling is dictated by specific heparan sulphate saccharides. Curr Biol. 1999;9(22):1343–1346.

18.

Pascal

Singer

Gish

. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-r1 complexed with a high affinity binding peptide. Cell. 1994;77(3):461–472.

19.

Schlessinger

. Cell signaling by receptor tyrosine kinases. Cell. 2000;103(2):211–225.

20.

Boilly

Vercoutter-Edouart

Hondermarck

Nurcombe

Le Bourhis

. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev. 2000;11(4):295–302.

21.

Kisseleva

Bhattacharya

Braunstein

Schindler

. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285(1-2):1–24.